Showing results 1 to 6 of 6
Development of new kinase inhibitors as targeted cancer therapeutics = 표적항암제로서 새로운 키나아제 저해제의 개발에 관한 연구link Hong, Seung-Hee; 홍승희; et al, 한국과학기술원, 2014 |
Discovery of Picomolar ABL Kinase Inhibitors Equipotent for Wild Type and T315I Mutant via Structure-Based de Novo Design Park, Hwangseo; Hong, Seunghee; Kim, Jinhee; Hong, Sungwoo, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, v.135, no.22, pp.8227 - 8237, 2013-06 |
HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia Yun, Sun-Mi; Jung, Kyung Hee; Kim, Soo Jung; Fang, Zhenghuan; Son, Mi Kwon; Yan, Hong Hua; Lee, Hyunseung; et al, CANCER LETTERS, v.348, no.1-2, pp.50 - 60, 2014-06 |
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation Kim, Soo Jung; Jung, Kyung Hee; Yan, Hong Hua; Son, Mi Kwon; Fang, Z; Ryu, Ye-Lim; Lee, Hyunseung; et al, ONCOTARGET, v.6, no.3, pp.1507 - 1518, 2015-01 |
Identification of common inhibitors of wild-type and T315I mutant of BCR-ABL through the parallel structure-based virtual screening Park, Hwangseo; Hong, Seunghee; Hong, Sungwoo, JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, v.26, no.8, pp.983 - 992, 2012-08 |
Structure-based design of flavone-based inhibitors of wild-type and T315I mutant of ABL Choe, Hyeonjeong; Kim, Jieun; Hong, Sungwoo, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.23, no.15, pp.4324 - 4327, 2013-08 |
Discover